Discontinuation report LATUDA
| Report ID | 272975 |
| Drug Identification Number | 02422050 |
| Brand name | LATUDA |
| Common or Proper name | lurasidone hydrochloride tablets |
| Company Name | SUMITOMO PHARMA CANADA, INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | LURASIDONE HYDROCHLORIDE |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | N05AE |
| ATC description | ANTIPSYCHOTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-06-30 |
| Actual discontinuation date | |
| Remaining supply date | 2026-06-30 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7025 LANGER DRIVE MISSISSAUGA, ONTARIO CANADA L5N 0E8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-12-01 | French | Compare |
| v1 | 2025-12-01 | English | Compare |
Showing 1 to 2 of 2